Skip Navigation
Skip to contents

JYMS : Journal of Yeungnam Medical Science



Page Path
HOME > J Yeungnam Med Sci > Volume 24(2 Suppl); 2007 > Article
Review Article Hybrid Coronary Revascularization
Sung Sae Han
Journal of Yeungnam Medical Science 2007;24(2 Suppl):S36-48
Published online: December 31, 2007
  • 1 Download
  • 0 Crossref
  • 0 Scopus
Department of Thoracic and Cardiovascular Surgery, College of Medicine, Yeungnam University, Daegu, Korea
Corresponding author:  Sung Sae Han, Tel: (053) 620-3881, Fax: (053) 620-8660, 

Hybrid coronary revascularization combines left internal mammary artery (LIMA) to left anterior descending artery (LAD) grafting integrated with percutaneous coronary intervention (PCI) on stenoses in the non-LAD territories. Hybrid coronary revascularization offers multivessel revascularization with minimal morbidity in high risk patients. Usually hybrid coronary revascularization performs minimally invasive direct coronary artery bypass grafting (MIDCAB) without cardiopulmonary bypass. The concept is now 10 year old. This procedure has been developed from MIDCAB plus percutaneous transluminal coronary angioplasty (PTCA) to totally endoscopic coronary artery bypass grafting (TECAB) procedures plus PTCA and drug-eluting stenting (DES). The hybrid coronary revascularization procedure may be especially useful in complex LAD lesions, restenotic lesions in LAD, acute myocardial infarction in “non-LAD” territory, high-risk elderly patients with multiple comorbidities and patients with severe left ventricular systolic dysfunction who are not ideal candidates for conventional bypass surgery. Hybrid coronary revascularization results according to the literature are very attractive. LIMA patency rates were found to be in the 98% range and restenosis rates in the PCI part of the procedure are in a 12% range.16) The wider introduction of hybrid revascularization is limited chiefly by the high number of repeat interventions compared with off-pump coronary artery bypass grafting, which occurs because of the target vessel failure rate of percutaneous coronary intervention. Drug-eluting stents substantially decrease the reintervention rate. However, the future role of hybrid coronary revascularization is unclear in patients with multivessel coronary artery disease involving the LAD if comparable results may be attained with multivessel PCI.

Related articles

JYMS : Journal of Yeungnam Medical Science